Anti-NBAS subunit of NRZ tethering complex Antibody Products

Anti-NBAS subunit of NRZ tethering complex antibodies are used for the immunodetection of the protein encoded by the NBAS gene. In humans, the canonical protein has a reported length of 2371 amino acid residues and a mass of 268.6 kDa. Its subcellular localization is in the membrane, ER, and cytoplasm. Alternative splicing is reported to yield 2 different isoforms for this protein. It is widely expressed across many tissues, with highest levels in the heart and skeletal muscle, and lowest levels in the liver, small intestine and thymus. It is known to be involved in Golgi-to-endoplasmic reticulum (ER) retrograde transport; the function is proposed to depend on its association in the NRZ complex which is believed to play a role in SNARE assembly at the ER. Other names for this target antigen include NAG, NAG/BC035112 fusion, NAG/FAM49A fusion, neuroblastoma amplified sequence, and ILFS2. Gene orthologs have been identified in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species.

Anti-NBAS subunit of NRZ tethering complex Antibody Products

Your search terms and filters produced no results.

Please use the Antibodies search tool above to find what you're looking for.

Suggested Products

  • S-RMab® Tau (pT217) IVD Antibody Pair – Precision Markers for Alzheimer’s Detection

    The S-RMab® Tau (pT217) IVD antibody pair (Capture S0B3533; Detector S0B3059) provides a powerful solution for Alzheimer’s disease research and clinical diagnostics. Developed using AntBio’s proprietary Single B-Cell and recombinant technologies, these antibodies demonstrate superior affinity, minimal batch variability, and outstanding stability for precise detection of Tau phosphorylated at threonine-217—a key neurodegenerative biomarker. Ideal for ELISA, CLIA, and other immunodiagnostic ...
  • KRAS Related Products

    KRAS is one of the most frequently mutated oncogenes in human cancers, playing a critical role in tumor initiation, progression, and therapeutic resistance. Mutations such as KRAS G12C, G12D, G12V, and G13D are commonly observed in lung, colorectal, and pancreatic cancers, making KRAS a high-value but historically challenging drug target. TargetMol provides KRAS-related products, including a comprehensive range of small-molecule inhibitors, biochemical tools, and research reagents designed to ...
  • <<
  • >>

Recent Product Review

Guided Browse

Browse Antibodies by Antigen

Browse Antibodies by Clone